SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-18-001160
Filing Date
2018-02-28
Accepted
2018-02-28 16:31:47
Documents
98
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2234657z10-k.htm 10-K 1692330
2 EX-21.1 a2234657zex-21_1.htm EX-21.1 3113
3 EX-23.1 a2234657zex-23_1.htm EX-23.1 3797
4 EX-31.1 a2234657zex-31_1.htm EX-31.1 8465
5 EX-31.2 a2234657zex-31_2.htm EX-31.2 8452
6 EX-32 a2234657zex-32.htm EX-32 10557
13 G734535.JPG g734535.jpg GRAPHIC 76761
14 G11323.JPG g11323.jpg GRAPHIC 97523
  Complete submission text file 0001047469-18-001160.txt   10206988

Data Files

Seq Description Document Type Size
7 EX-101.INS tbph-20171231.xml EX-101.INS 2691719
8 EX-101.SCH tbph-20171231.xsd EX-101.SCH 68598
9 EX-101.CAL tbph-20171231_cal.xml EX-101.CAL 64626
10 EX-101.DEF tbph-20171231_def.xml EX-101.DEF 300017
11 EX-101.LAB tbph-20171231_lab.xml EX-101.LAB 621196
12 EX-101.PRE tbph-20171231_pre.xml EX-101.PRE 523415
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36033 | Film No.: 18651725
SIC: 2834 Pharmaceutical Preparations